Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 4/20 | 0.49 |
| ▸ | PIK3CD | O00329 | 12/20 | 0.43 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.43 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.43 |
| ▸ | PIK3CG | P48736 | 2/20 | 0.43 |
| ▸ | EPHA2 | P29317 | 4/20 | 0.43 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.42 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30140298 | 1.00 | GPR119 (0.49) | GPR119PIK3CDPIK3CAPIK3CBPIK3CG | |
| SCHEMBL30140109 | 0.90 | GPR119 (0.53) | GPR119PIK3CDPIK3CAPIK3CBPIK3CG | |
| SCHEMBL30140158 | 0.90 | GPR119 (0.43) | GPR119PIK3CDPIK3CAPIK3CBPIK3CG | |
| SCHEMBL30140290 | 0.90 | GPR119 (0.43) | GPR119PIK3CDPIK3CAPIK3CBPIK3CG | |
| SCHEMBL30140260 | 0.89 | EGFR (0.49) | ERBB2 | |
| SCHEMBL30140136 | 0.89 | EGFR (0.49) | ERBB2 | |
| SCHEMBL30140128 | 0.89 | GPR119 (0.49) | GPR119PIK3CDPIK3CAPIK3CBPIK3CG | |
| SCHEMBL30140079 | 0.89 | GPR119 (0.49) | GPR119PIK3CDPIK3CAPIK3CBPIK3CG | |
| SCHEMBL30140215 | 0.85 | GPR119 (0.52) | GPR119PIK3CDPIK3CAPIK3CBPIK3CG | |
| SCHEMBL30140184 | 0.84 | GPR119 (0.55) | GPR119PIK3CDPIK3CAPIK3CBPIK3CG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022266426-A1 | 6-(HETEROCYCLOALKYL-OXY)-QUINAZOLINE DERIVATIVES AND USES THEREOF | BLACK DIAMOND THERAPEUTICS, INC. (US) | 2022-12-22 | — | — | WO | disclosed |